Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease

16Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Glucocorticoids (GCs) are widely used immunosuppressive drugs for autoimmune diseases, although considerable gaps exist between current knowledge of the mechanisms of GCs and their conclusive immune-regulatory effects. Here we generated a single-cell transcriptional immune cell atlas based on prednisone-treated or untreated experimental autoimmune uveitis (EAU) mice. Immune cells were globally activated in EAU, and prednisone partially reversed this effect in terms of cell composition, gene expression, transcription factor regulation, and cell-cell communication. Prednisone exerted considerable rescue effects on T and B cells and increased the proportion of neutrophils. Besides commonly regulated transcriptional factors (Fosb, Jun, Jund), several genes were only regulated in certain cell types (e.g. Cxcr4 and Bhlhe40 in T cells), suggesting cell-type-dependent immunosuppressive properties of GC. These findings provide new insights into the mechanisms behind the properties and cell-specific effects of GCs and can potentially benefit immunoregulatory therapy development.

Cite

CITATION STYLE

APA

Li, H., Gao, Y., Xie, L., Wang, R., Duan, R., Li, Z., … Su, W. (2021). Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.739605

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free